
Theratechnologies THTX
Geschäftsbericht 2024
hinzugefügt 11.04.2026
Theratechnologies DIO 2011-2026 | THTX
DIO Jährlich Theratechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 373 | 672 | 1.15 K | 1.58 K | 1.05 K | - | 92.2 K |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 92.2 K | 373 | 16.2 K |
DIO anderer Aktien in der Pharmaeinzelhändler
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
2.46 K | $ 2.14 | -1.38 % | $ 445 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
166 | $ 20.47 | 0.49 % | $ 957 M | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.19 | -0.24 % | $ 6.83 B | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Halozyme Therapeutics
HALO
|
254 | $ 67.06 | -1.12 % | $ 8.04 B | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Harmony Biosciences Holdings
HRMY
|
11.6 | $ 28.69 | -0.69 % | $ 1.65 B | ||
|
Akebia Therapeutics
AKBA
|
147 | $ 1.41 | 0.71 % | $ 363 M | ||
|
Aquestive Therapeutics
AQST
|
120 | $ 4.16 | 1.84 % | $ 445 M | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 24.01 | -0.85 % | $ 3.05 B | ||
|
ImmuCell Corporation
ICCC
|
185 | $ 7.12 | 1.14 % | $ 64.3 M | ||
|
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.48 | -0.67 % | $ 394 M | ||
|
Incyte Corporation
INCY
|
78.4 | $ 94.86 | -1.26 % | $ 18.5 B | ||
|
Aytu BioScience
AYTU
|
209 | $ 2.61 | 2.35 % | $ 16.4 M | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B |